BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16250368)

  • 1. Initial treatment patterns for clinically localized prostate cancer and factors associated with the treatment in Louisiana.
    Wu X; Chen VW; Andrews PA; Chen L; Ahmed MN; Schmidit B; Hsieh M; Fontham ET
    J La State Med Soc; 2005; 157(4):188-94. PubMed ID: 16250368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
    Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
    J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative importance of PSA in prostate cancer treatment.
    Unger HA; Kane RD; Fox KM; Gandhi S; Alzola C; Lamerato L; Newling D; Kumar S
    Urol Oncol; 2005; 23(4):238-45. PubMed ID: 16018938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening.
    Yan Y; Carvalhal GF; Catalona WJ; Young JD
    Cancer; 2000 Mar; 88(5):1122-30. PubMed ID: 10699903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostate cancer management and factors associated with radical prostatectomy in France in 2001].
    Jegu J; Tretarre B; Velten M; Guizard AV; Danzon A; Buemi A; Colonna M; Kadi-Hanifi AM; Ganry O; Molinie F; Bara S; Rebillard X; Grosclaude P
    Prog Urol; 2010 Jan; 20(1):56-64. PubMed ID: 20123529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.
    Tewari A; Divine G; Chang P; Shemtov MM; Milowsky M; Nanus D; Menon M
    J Urol; 2007 Mar; 177(3):911-5. PubMed ID: 17296374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.
    Hoffman RM; Barry MJ; Stanford JL; Hamilton AS; Hunt WC; Collins MM
    Am J Med; 2006 May; 119(5):418-25. PubMed ID: 16651054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
    Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
    BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent.
    Lippert MC; McClain R; Boyd JC; Theodorescu D
    Cancer; 1999 Dec; 86(12):2642-8. PubMed ID: 10594859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.
    Litwin MS; Lubeck DP; Spitalny GM; Henning JM; Carroll PR
    Cancer; 2002 Jul; 95(1):54-60. PubMed ID: 12115317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
    D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
    J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer.
    Liu L; Coker AL; Du XL; Cormier JN; Ford CE; Fang S
    J Surg Oncol; 2008 Jun; 97(7):583-91. PubMed ID: 18381603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.
    Tsai HK; Chen MH; McLeod DG; Carroll PR; Richie JP; D'Amico AV
    Cancer; 2006 Dec; 107(11):2597-603. PubMed ID: 17039498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
    Albertsen PC; Hanley JA; Penson DF; Barrows G; Fine J
    J Urol; 2007 Mar; 177(3):932-6. PubMed ID: 17296379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.